TMO vs DXCM
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs DexCom, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | DXCM |
|---|---|---|
| Price | $675.00 | $86.62 |
| Market cap | $249.58B | $32.69B |
| P/E ratio | 36.4 | 34.2 |
| ROE | 13.51% | 38.49% |
| Profit margin | 15.04% | 20.12% |
| Revenue growth | 10.50% | 13.10% |
| Dividend yield | 0.28% | — |
| Beta | 0.85 | 1.42 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs DXCM in plain English
- TMO is the bigger company — about 7.6× the market cap of DXCM.
- DXCM is cheaper on earnings (P/E 34.2 vs 36.4).
- DXCM earns a higher return on equity (38% vs 14%).
- DXCM is growing revenue faster (13% vs 10%).
- TMO pays a dividend (0.28%) while the other effectively doesn't.
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
DXCM return calculator
See what $1,000 in DexCom, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.